RXRX vs U · rev $58.8M vs rev $1.85B
Recursion Pharmaceuticals Inc (RXRX) versus Unity Software Inc (U) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Unity Software Inc (U) is a software - application company listed on US.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
Latest reported U revenue for 2025-12-31 was $1.85B. Net income was -$402.8M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. U currently screens at market cap $16.98B.
RXRX currently screens at market cap $1.75B. U currently screens at market cap $16.98B.
Not investment advice. Open the RXRX and U stock pages for the full models.
Not investment advice.